Join
Live feed
·
PRReleasevia Quantisnow
Nexentis Technologies Inc. logo

Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board

ByQuantisnow·Wall Street's wire, on your screen.
NXTS· Nexentis Technologies Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NXTS (Nexentis Technologies Inc.) and more on Quantisnow.